Virginia Pérez-Andreu

2.0k total citations
13 papers, 516 citations indexed

About

Virginia Pérez-Andreu is a scholar working on Pharmacology, Molecular Biology and Hematology. According to data from OpenAlex, Virginia Pérez-Andreu has authored 13 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Molecular Biology and 3 papers in Hematology. Recurrent topics in Virginia Pérez-Andreu's work include Pharmacogenetics and Drug Metabolism (5 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Virginia Pérez-Andreu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Virginia Pérez-Andreu collaborates with scholars based in Spain, Guatemala and United Kingdom. Virginia Pérez-Andreu's co-authors include Vicente Vicente, Vanessa Roldán, Javier Corral, Nuria García‐Barberá, Rocío Gónzález‐Conejero, Constantino Martı́nez, Ana Isabel Antón, Irene Martínez‐Martínez, R Ayats and Carlos Salvador and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Virginia Pérez-Andreu

13 papers receiving 506 citations

Peers

Virginia Pérez-Andreu

GENET

HEMAT

RHEUM

PHARM

Ping Chong Bee Malaysia

Nuria García‐Barberá Spain

Devron R. Shah United Kingdom

Herbert Birnboeck Switzerland

J. L. Beaumont France

Friederike Kanefendt Germany

John Houghton United Kingdom

José Padilla Spain

Yi Ling Teo Singapore

Shigenori Kanazawa Japan

Ping Chong Bee Malaysia

Virginia Pérez-Andreu

99 ×0.5

84 ×0.5

GENET

151 ×1.1

HEMAT

44 ×0.4

RHEUM

66 ×0.6

PHARM

Citations per year, relative to Virginia Pérez-Andreu Virginia Pérez-Andreu (= 1×) peers Ping Chong Bee

Countries citing papers authored by Virginia Pérez-Andreu

Since Specialization

Citations

This map shows the geographic impact of Virginia Pérez-Andreu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Pérez-Andreu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Pérez-Andreu more than expected).

Fields of papers citing papers by Virginia Pérez-Andreu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Pérez-Andreu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Pérez-Andreu. The network helps show where Virginia Pérez-Andreu may publish in the future.

Co-authorship network of co-authors of Virginia Pérez-Andreu

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Pérez-Andreu. A scholar is included among the top collaborators of Virginia Pérez-Andreu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Pérez-Andreu. Virginia Pérez-Andreu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Archer, Natalie P., Virginia Pérez-Andreu, Ulrik Kristoffer Stoltze, et al.. (2017). Family-based exome-wide association study of childhood acute lymphoblastic leukemia among Hispanics confirms role of ARID5B in susceptibility. PLoS ONE. 12(8). e0180488–e0180488. 15 indexed citations

Archer, Natalie P., Virginia Pérez-Andreu, Michael E. Scheurer, et al.. (2016). Family‐based exome‐wide assessment of maternal genetic effects on susceptibility to childhood B‐cell acute lymphoblastic leukemia in hispanics. Cancer. 122(23). 3697–3704. 15 indexed citations

Antón, Ana Isabel, José Padilla, Virginia Pérez-Andreu, et al.. (2013). Novel Associations of VKORC1 Variants with Higher Acenocoumarol Requirements. PLoS ONE. 8(5). e64469–e64469. 15 indexed citations

Pérez-Andreu, Virginia, Javier Corral, Vanessa Roldán, et al.. (2012). miR-133a Regulates Vitamin K 2,3-Epoxide Reductase Complex Subunit 1 (VKORC1), a Key Protein in the Vitamin K Cycle. Molecular Medicine. 18(11). 1466–1472. 26 indexed citations

Antón, Ana Isabel, Virginia Pérez-Andreu, Nuria García‐Barberá, et al.. (2012). Creating a genotype-based dosing algorithm for acenocoumarol steady dose. Thrombosis and Haemostasis. 109(1). 146–153. 24 indexed citations

Pérez‐Sánchez, C., Javier Corral, M. Herranz, et al.. (2011). Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. 9(10). 1985–1992. 101 indexed citations

Corral, Javier, et al.. (2011). Potential Role of miRNAs in Developmental Haemostasis. PLoS ONE. 6(3). e17648–e17648. 25 indexed citations

Álvarez‐Larrán, Alberto, Francisco Cervantes, Arturo Pereira, et al.. (2010). Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia. Blood. 116(8). 1205–1210. 164 indexed citations

Pérez-Andreu, Virginia, Vanessa Roldán, María Fernanda López Fernández, et al.. (2010). Pharmacogenetics of acenocoumarol in patients with extreme dose requirements. Journal of Thrombosis and Haemostasis. 8(5). 1012–1017. 18 indexed citations

10.

Hernández‐Romero, Diana, Juan M. Ruiz-Nodar, Francisco Marı́n, et al.. (2010). CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis. Annals of Medicine. 42(6). 439–446. 8 indexed citations

11.

Pérez-Andreu, Virginia, Vanessa Roldán, Rocío Gónzález‐Conejero, et al.. (2009). Implications of Pharmacogenetics for Oral Anticoagulants Metabolism. Current Drug Metabolism. 10(6). 632–642. 10 indexed citations

12.

Pérez-Andreu, Virginia, Vanessa Roldán, Ana Isabel Antón, et al.. (2009). Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy. Blood. 113(20). 4977–4979. 57 indexed citations

13.

Marı́n, Francisco, José Sánchez–Payá, José Valencia Martín, et al.. (2008). Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. European Heart Journal. 30(8). 932–939. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact